Concepedia

Jess Savala

JS

Statistics

Publications

5

Citations

224

H-Index

5

Active since

2018

Affiliations

PreludeDx (United States)(Current)

Cleveland Clinic

Karolinska Institutet

Uppsala University

University of Gothenburg

Jess Savala is an author at PreludeDx (United States) specializing in clinical trials, radiation therapy, and radiation effects.

Top concepts

Publications per year

2018–2023

5

Publications

5

A Biological Signature for Breast Ductal Carcinoma <i>In Situ</i> to Predict Radiotherapy Benefit and Assess Recurrence Risk

Troy Bremer, Pat W. Whitworth, Rakesh Patel et al. · Clinical Cancer Research · 2018 · 121 citations

Prognostic Risk Assessment and Prediction of Radiotherapy Benefit for Women with Ductal Carcinoma In Situ (DCIS) of the Breast, in a Randomized Clinical Trial (SweDCIS)

Fredrik Wärnberg, Per Karlsson, Erik Holmberg et al. · Cancers · 2021 · 49 citations · Full text

A Novel Biosignature Identifies Patients With DCIS With High Risk of Local Recurrence After Breast Conserving Surgery and Radiation Therapy

Frank A. Vicini, G. Bruce Mann, Chirag Shah et al. · International Journal of Radiation Oncology*Biology*Physics · 2022 · 33 citations · Full text

Analytical validation of the 7-gene biosignature for prediction of recurrence risk and radiation therapy benefit for breast ductal carcinoma in situ

David J. Dabbs, Karuna Mittal, SCOTT HEINEMAN et al. · Frontiers in Oncology · 2023 · 11 citations · Full text

Abstract GS5-08: A validation of DCIS biological risk profile in a randomised study for radiation therapy with 20 year follow-up (SweDCIS)

Fredrik Wärnberg, Hans Garmo, Yasin Folkvaljon et al. · Cancer Research · 2018 · 10 citations

, , +23

1–5 of 5